CD56 Antibody Kit, anti-human, FITC, REAlease® from MILTENYI BIOTEC B.V. & Co. KG

Search, find, compare suppliers for CD56 Antibody Kit, anti-human, FITC, REAlease® products.

Edit 
Product NameCD56 Antibody Kit, anti-human, FITC, REAlease®
DescriptionCD56 Antibody Kit, anti-human, FITC, REAlease®. Clone REAL274 is an antibody fragment derived from the full CD56 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAlease Complex to bind markers with high avidity. | Clone REAL274 recognizes the human CD56 antigen, a glycoprotein of the Ig-superfamily, also known as neural cell adhesion molecule (NCAM), which is expressed in blood on practically all resting and activated NK cells and on a minor subset of CD3+ T cells. CD56 is also expressed in brain (cerebellum and cortex) and at neuromuscular junctions. Certain large granular lymphocyte (LGL) leukemias, small-cell lung carcinomas, neuronal-derived tumors, myelomas, and myeloid leukemias also express CD56. | The REAlease Kits consist of the respective fluorochrome-conjugated REAlease Complexes and the REAlease Support Kit for removal of the REAlease Complexes and optional relabeling with different fluorochrome-conjugated REAlease Complexes.
Size100 tests
Concentration1:50
ApplicationsFlow cytometry
Other NamesNCAM1, MSK39, NCAM
Gene, Accession, CAS #n/a
Catalog #130-122-711
Price$375
Order / More InfoCD56 Antibody Kit, anti-human, FITC, REAlease® from MILTENYI BIOTEC B.V. & Co. KG
Product Specific ReferencesCamp, B. V. et al. (1990) Plasma cells in multiple myeloma express a natural killer cell- associated antigen: CD56 (NKH-1; Leu-19). Blood 76: 377-382.
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197

macs@miltenyibiotec.de

https://www.miltenyibiotec.com

Profile of MILTENYI BIOTEC B.V. & Co. KG

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.